Re:Anthropic hits $2T in Nasdaq debut
by abixb on Thursday November 19, 2026 @02:39PM
(#50565159)
> He has an investor for USD 1 million for a Phase 1 cancer drug and is struggling.
Well, the market is betting on the fact that Phase 1 trials for such critical drugs can be fully modeled on digital twins running on GPUS, so they can leapfrog needing human subjects for RCTs.
Well, the market is betting on the fact that Phase 1 trials for such critical drugs can be fully modeled on digital twins running on GPUS, so they can leapfrog needing human subjects for RCTs.
Not disagreeing with you, though.